OST-122

N/A

Report date: 2024/04/01 16:47:52
NME

Base Information

Drug NameOST-122
Drug Alias NameOST-122
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase 2 inhibitorsTyrosine-protein kinase JAK3 inhibitorsNUAK family SNF1-like kinase 1 inhibitors
TargetsTyrosine-protein kinase 2Tyrosine-protein kinase JAK3NUAK family SNF1-like kinase 1
Therapy Area/IndicationsFibrosisInflammatory Bowel DiseasesColitis, Ulcerative +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUkraineSpain
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesOncostellae Sl
China Registration ClassN/A

Develop Information

Active CompaniesOncostellae Sl
Inactive CompaniesN/A
Active IndicationsFibrosisInflammatory Bowel DiseasesColitis, Ulcerative +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A